Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 10, 2011, Pages 1265-1273

  Dew, Noel ^a   Edsman, Katarina ^a   Björk, Erik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

catanionic; gel; pig ear skin; silicone membrane; vesicle

Indexed keywords

DECANOIC ACID; DODECYL SULFATE SODIUM; POLYMER; SILICONE; TETRACAINE;

ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG ABSORPTION; DRUG DIFFUSION; EX VIVO STUDY; FLOW KINETICS; GEL; NONHUMAN; SKIN PERMEABILITY; SKIN STRUCTURE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; SWINE;

ACRYLIC RESINS; ANIMALS; CATIONS; CHEMISTRY, PHARMACEUTICAL; DECANOIC ACIDS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GELS; POLYMERS; REFERENCE VALUES; RHEOLOGY; SKIN; SKIN ABSORPTION; SODIUM DODECYL SULFATE; SWINE; TETRACAINE;

EID: 80052564088     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01339.x     Document Type: Article

References (52)

1. Carlfors J, et al,. Rheological evaluation of Gelrite (R) in situ gels for ophthalmic use. Eur J Pharm Sci 1998; 6: 113-119. (Pubitemid 28164281)
2. Edsman K, Hagerstrom H,. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005; 57: 3-22. (Pubitemid 40030097)
3. Bramer T, et al,. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels. J Pharm Sci 2006; 95: 769-780.
4. Bramer T, et al,. Effects of pH and ionic strength on catanionic drug-surfactant mixtures used for prolonged release from gels. J Drug Deliv Sci Tec 2007; 17: 285-291. (Pubitemid 47395781)
5. Bramer T, et al,. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels. Pharm Res 2003; 20: 1661-1667. (Pubitemid 37268284)
6. Dew N, et al,. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels. J Colloid Interface Sci 2008; 323: 386-394.
7. Dew N, et al,. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer. Colloids Surf B Biointerfaces 2009; 70: 187-197.
8. Paulsson M, Edsman K,. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants. Pharm Res 2001; 18: 1586-1592. (Pubitemid 33022415)
9. Bramer T, et al,. Pharmaceutical applications for catanionic mixtures. J Pharm Pharmacol 2007; 59: 1319-1334. (Pubitemid 47606446)
10. Kaler EW, et al,. Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants. Science 1989; 245: 1371-1374. (Pubitemid 19252601)
11. Tondre C, Caillet C,. Properties of the amphiphilic films in mixed cationic/anionic vesicles: a comprehensive view from a literature analysis. Adv Colloid Interface Sci 2001; 93: 115-134. (Pubitemid 32821006)
12. Antunes FE, et al,. Network formation of catanionic vesicles and oppositely charged polyelectrolytes. Effect of polymer charge density and hydrophobic modification. Langmuir 2004; 20: 4647-4656.
13. Marques EF, et al,. Interactions between catanionic vesicles and oppositely charged polyelectrolytes-phase behavior and phase structure. Macromolecules 1999; 32: 6626-6637.
14. Ashbaugh HS, et al,. Gelation of 'catanionic' vesicles by hydrophobically modified polyelectrolytes. Colloid Polym Sci 2002; 280: 783-788. (Pubitemid 36075851)
15. Lee JH, et al,. Vesicle-biopolymer gels: networks of surfactant vesicles connected by associating biopolymers. Langmuir 2005; 21: 26-33.
16. Medronho B, et al,. Gels of catanionic vesicles and hydrophobically modified poly(ethylene glycol). J Disper Sci Technol 2006; 27: 83-90. (Pubitemid 43123490)
17. Mezei M, Gulasekharam V,. Liposomes-a selective drug delivery system for the topical route of administration-gel dosage form. J Pharm Pharmacol 1982; 34: 473-474. (Pubitemid 12082555)
18. Michel C, et al,. Effect of liposomes on percutaneous penetration of lipophilic materials. Int J Pharm 1992; 84: 93-105.
19. Wang JL, et al,. Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel. J Mater Sci Mater Med 2009; 20: 2075-2084.
20. Maestrelli F, et al,. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009; 19: 253-260.
21. Michaels AS, et al,. Drug permeation through human skin-theory and in vitro experimental measurement. AIChE J 1975; 21: 985-996.
22. Kirjavainen M, et al,. Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta 1996; 1304: 179-189. (Pubitemid 26426990)
23. Mezei M, Gulasekharam V,. Liposomes-a selective drug delivery system for the topical route of administration. 1. Lotion dosage form. Life Sci 1980; 26: 1473-1477. (Pubitemid 10042852)
24. Cevc G,. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004; 56: 675-711. (Pubitemid 38326939)
25. Maghraby GM, et al,. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008; 34: 203-222.
26. Consola S, et al,. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery. Chemistry 2007; 13: 3039-3047. (Pubitemid 46941833)
27. Östh K, et al,. Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber. J Control Release 2002; 83: 377-388. (Pubitemid 35223260)
28. Barbero AM, Frasch HF,. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 2009; 23: 1-13.
29. Foldvari M, et al,. Topical dosage form of liposomal tetracaine-effect of additives on the in-vitro release and in-vivo efficacy. J Control Release 1993; 27: 193-205. (Pubitemid 24015722)
30. Geinoz S, et al,. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm Res 2002; 19: 1622-1629. (Pubitemid 35305513)
31. Hou SYE, Flynn GL,. Influences of 1-dodecylazacycloheptan-2-one on permeation of membranes by weak electrolytes. 1. Theoretical analysis of weak electrolyte diffusion through membranes and studies involving silicone rubber membranes. J Pharm Sci 1997; 86: 85-91. (Pubitemid 127489663)
32. Vlachy N, et al,. Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells. Colloids Surf B Biointerfaces 2009; 70: 278-280.
33. Fulmer AW, Kramer GJ,. Stratum-corneum lipid abnormalities in surfactant-induced dry scaly skin. J Invest Dermatol 1986; 86: 598-602. (Pubitemid 16052567)
34. Hall-Manning TJ, et al,. Skin irritation potential of mixed surfactant systems. Food Chem Toxicol 1998; 36: 233-238. (Pubitemid 28435112)
35. Kabara J,. Toxicological, bacteriocidal and fungicidal properties of fatty acids and some derivatives. J Am Oil Chem Soc 1979; 56: 760A-767A.
36. Bagley DM, et al,. Skin irritation: reference chemicals data bank. Toxicol In Vitro 1996; 10: 1-6. (Pubitemid 26077098)
37. Wilhelm KP, et al,. Effect of sodium lauryl sulfate-induced skin irritation on in vivo percutaneous penetration of four drugs. J Invest Dermatol 1991; 97: 927-932.
38. Aungst BJ,. Structure effect studies of fatty-acid isomers as skin penetration enhancers and skin irritants. Pharm Res 1989; 6: 244-247.
39. Aungst BJ, et al,. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty-acids and amines. Pharm Res 1990; 7: 712-718. (Pubitemid 20278367)
40. Chi S-C, et al,. Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 1995; 126: 267-274. (Pubitemid 26015642)
41. Chien YW, et al,. Transdermal controlled administration of indomethacin. 1. Enhancement of skin permeability. Pharm Res 1988; 5: 103-106.
42. Fang C, et al,. Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur J Pharm Biopharm 2008; 68: 735-740. (Pubitemid 351318188)
43. Fisher R, et al,. Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. Br J Anaesth 1998; 81: 972-973. (Pubitemid 28561338)
44. Woolfson AD, et al,. Development and characterisation of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia. Int J Pharm 1998; 169: 83-94. (Pubitemid 28352601)
45. Zempsky WT, Karasic RB,. EMLA versus TAC for topical anesthesia of extremity wounds in children. Ann Emerg Med 1997; 30: 163-166. (Pubitemid 27334899)
46. Almdal K, et al,. Towards a phenomenological definition of the term 'gel'. Polymer Gels Netw 1993; 1: 5-17.
47. Ross-Murphy SB, McEvoy H,. Fundamentals of hydrogels and gelation. Brit Polym J 1986; 18: 2-7.
48. Higuchi WI,. Analysis of data on the medicament release from ointments. J Pharm Sci 1962; 51: 802-804.
49. Ritger PL, Peppas NA,. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23-26.
50. Bramer T, et al,. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels. Colloids Surf B Biointerfaces 2009; 71: 214-225.
51. Brohede U, et al,. Electrodynamic investigations of ion transport and structural properties in drug-containing gels: dielectric spectroscopy and transient current measurements on catanionic carbopol systems. J Phys Chem B 2005; 109: 15250-15255. (Pubitemid 41260766)
52. Fartasch M,. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech 1997; 37: 193-199. (Pubitemid 27197739)